SAC Capital Advisors LP - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 99 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 2.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
SAC Capital Advisors LP ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2014$40,565,000
-17.4%
3,411,659
-4.0%
0.21%
-26.0%
Q4 2013$49,101,000
-31.3%
3,555,500
-13.2%
0.28%
-26.4%
Q3 2013$71,451,000
+137.9%
4,094,600
+121.6%
0.39%
+134.5%
Q2 2013$30,029,0001,847,9430.16%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
BVF INC/IL 15,232,268$29,094,0002.84%
EcoR1 Capital, LLC 412,000$787,0000.08%
PLATINUM INVESTMENT MANAGEMENT LTD 1,130,432$2,159,0000.05%
ESSEX INVESTMENT MANAGEMENT CO LLC 164,605$314,0000.04%
Clear Harbor Asset Management, LLC 95,630$183,0000.03%
ALGERT GLOBAL LLC 72,556$139,0000.03%
180 WEALTH ADVISORS, LLC 30,000$57,0000.03%
GSA CAPITAL PARTNERS LLP 289,854$554,0000.03%
PRELUDE CAPITAL MANAGEMENT, LLC 85,412$163,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 459,000$877,0000.01%
View complete list of INFINITY PHARMACEUTICALS INC shareholders